Navigation Links
ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
Date:8/14/2008

BROOMFIELD, Colo., Aug. 14 /PRNewswire/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, announced today that it has appointed William R. Hiatt, MD, as Director of Clinical and Regulatory Strategy. In this newly created position, Dr. Hiatt will be responsible for developing strategic regulatory and clinical initiatives designed to support the company's lead product candidate, Gencaro(TM) (bucindolol hydrochloride), a pharmacologically unique beta-blocker and mild vasodilator in late-stage development for heart failure, as well as other compounds in ARCA's pipeline.

"Dr. Hiatt is a recognized expert who knows cardiovascular medicine from virtually every angle: as researcher, physician, educator, clinician and former advisor to the U.S. Food and Drug Administration," said Richard B. Brewer, president and chief executive officer of ARCA biopharma. "He brings valuable experience and insight to ARCA as we prepare to introduce our first product and begin to educate the medical community about the benefits of genetically targeted treatment of heart failure."

"I look forward to working with the talented men and women at ARCA to bring important new solutions to heart failure patients," said Dr. William Hiatt. "By inaugurating the personalized medicine trail in the heart failure arena, ARCA is changing the way we offer treatment to patients with this serious chronic condition."

Dr. Hiatt is Professor of Medicine, Professor of Cardiovascular Research and Chief of the Section of Vascular Medicine at the University of Colorado Denver's Anschutz Medical Campus. Throughout his career, Dr. Hiatt's research has focused on developing new therapies for patients with peripheral arterial disease and understanding its pathophysiology in terms of the effects of muscle ischemia on muscle metabolism and function. Dr. Hiatt also is President of the Colorado Preventio
'/>"/>

SOURCE ARCA biopharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Ondine Biopharma Announces Second Quarter 2008 Financial Results
2. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
4. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
5. ARCA biopharma Appoints James Carr as Vice President of Marketing
6. TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) Roaming Credentials
7. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
8. CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
9. PacificGMP to Merge With Pacific Biopharma Group and Create Innovative US-Compliant cGMP Contract Biomanufacturing Facility in China
10. Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008
11. XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... , May 23, 2013 BioTrends ... and advisory firms for specialized biopharmaceutical issues, finds ... and infectious disease specialists reported that in the ... (e.g., intentionally delaying treatment) in anticipation of the ... six months ago, when only 6 percent reported ...
(Date:5/23/2013)... Ill. , May 23, 2013 Z ... providing value-added ingredients to a variety of industries, announced ... in a panel discussion at this year,s National Restaurant ... 20-21, 2013, on behalf of the Research Chefs Association.  ... for Restaurants: The Good, the Bad and the Ugly," ...
(Date:5/23/2013)... The New Jersey chapter of the largest organization ... (BDPA), is hosting its 10th annual Families in Technology ... will encourage students and their parents to explore the ... many of the industries’ finest teachers. Held from 9 ... of Technology, the event will include workshops, instruction and ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2
... Therapeutics, Inc.,(Nasdaq: HALO ), a biopharmaceutical company ... today announced that David,Ramsay, Halozyme,s Vice President and ... in February. Mr. Ramsay will present an,overview of ... milestones at,each conference., -- 10th ...
... Flurizan Will Earn a 23%,Patient Share in the United States, According to ... ... WALTHAM, Mass., Feb. 5 Decision Resources, one of the,world,s leading ... drug,s effect on delaying the progression,from mild cognitive impairment to Alzheimer,s disease ...
... Presenting at BIO CEO & Investor Conference, LOUISVILLE, Colo., ... that it will host a conference call on,Tuesday, February 26, ... year-end earnings. Additionally, Replidyne will present at an upcoming,investor conference ... as follows:, Kenneth J. Collins, President and ...
Cached Biology Technology:Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference 2Flurizan's Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimer's Disease is Superior to That of Aricept 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3
(Date:5/24/2013)... the world,s largest and fastest growing open-access publishers, today ... in Physics . , A broad scope journal covering ... an open-science and interactive web platform for the research ... , Frontiers, real-time and interactive peer-review enables fast, ... types. With an average of three months from submission ...
(Date:5/24/2013)... the search for medication against Alzheimer,s disease, scientists have focused ... down Amyloid beta (A-beta). After all, it is the accumulation ... of Alzheimer,s patients. Starting point for the formation of A-beta ... the first to unravel the function of APPL the ... fruit flies. , Alessia Soldano (VIB/KU Leuven): "We have ...
(Date:5/23/2013)... more than 284 million tons of cargo, transit the Panama ... fees for the Panama Canal Authority. Each time a ship ... used from Gatun Lake, which is also a source of ... , However, the advent of very large "super" cargo ... sea, has demanded change. The Panama Canal is being expanded ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3A new strategy required in the search for Alzheimer's drugs? 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... Carolina is a rapidly growing city. Charlotte is also ... a contradiction. , In Charlotte, there are wooded lots ... the towers of the nation,s second largest financial center. ... within the city,s boundaries. Social scientists find the co-existence ...
... It seems the old nature versus nurture debate can,t be ... the Philippines makes a strong case for nurture,s role in ... in the first six months of life predicts earlier puberty ... babies -- an indication that they were not nutritionally stressed ...
... YORK, NY, September 13, 2010) A new study led ... novel molecular pathway underlying Parkinson,s disease and points to existing ... disease. The pathway involved proteins known as polyamines ... in build-up of other toxic proteins in neurons, which causes ...
Cached Biology News:Interdisciplinary research looks at Charlotte's green mystery 2Interdisciplinary research looks at Charlotte's green mystery 3Interdisciplinary research looks at Charlotte's green mystery 4Interdisciplinary research looks at Charlotte's green mystery 5Interdisciplinary research looks at Charlotte's green mystery 6Male maturity shaped by early nutrition 2Male maturity shaped by early nutrition 3New pathway identified in Parkinson's through brain imaging 2New pathway identified in Parkinson's through brain imaging 3New pathway identified in Parkinson's through brain imaging 4
Dnase and Rnase free...
TLN2 Antibody...
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778 ...
Rabbit polyclonal to VEGF Receptor 2 (phospho Y1214) ( Abpromise for all tested applications). entrezGeneID: 3791 SwissProtID: P35968...
Biology Products: